Results 11 to 20 of about 10,780 (181)
Detection and clinical significance of anti-carbamylated protein antibody in serologically negative patients with rheumatoid arthritis [PDF]
Xin yixue, 2022 Objective To probe into the level and clinical significance of anti-carbamylated protein （CarP） antibody in serologically negative patients with rheumatoid arthritis （RA）.
Wu Tao, Chen Chutao, Yang Lijuan, Zou Yaowei, Ma Jianda, Xu Yanhui, Jia Lei, Dai Lie
doaj +1 more source
AB0207 CLINICAL IMPACT OF ANTI-CARP ANTIBODIES IN RHEUMATOID ARTHRITIS [PDF]
Annals of the Rheumatic Diseases, 2020 Background: Antibodies directed against carbamylated proteins (anti-CarP) have been recently introduced for the first time as a new biomarker in rheumatoid arthritis (RA) (1). Their presence is predictive for the development of RA (2). Anti-CarP antibodies are associated with the development of more severe forms of the disease in overall and anti ...
M. Markovic, B. Glisic, M. Petronijevic
openaire +1 more source
Anti-carbamylated protein antibodies in systemic sclerosis
Arthritis Research & Therapy, 2023 Background To investigate the presence of different isotypes of anti-carbamylated protein (CarP) antibodies in systemic sclerosis (SSc) patients and its association with skin involvement.
Sophie I. E. Liem +8 more
doaj +1 more source
Rheumatoid arthritis and the proinflammatory cytokine IL-17 [PDF]
Folia Medica, 2023 Introduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease. Various proinflammatory cytokines are involved in the pathogenesis of this chronic disorder.
Pavel Selimov +8 more
doaj +3 more sources
THU0139 IS ADDING ANTI-CARP OR ANTI-PADI4 BENEFICIAL FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS? [PDF]
Annals of the Rheumatic Diseases, 2019 Background Post-translatory modification (PTM), such as protein citrullination or homocitrullination (carbamylation) are key issues for the development of RA. There are known more than 300 PTMs. Some of them such as homocitrullination, are of chemical origin, but most of them (over 200) are of enzymatic origin.
Bogdan Kolarz +3 more
openaire +2 more sources
Research progress on anti-carbamylated protein antibodies in connective tissue disease [PDF]
Xin yixue, 2023 Connective tissue disease （CTD） is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies.
Dong Rongrong, Yang Qingrui, Ma Zhenzhen
doaj +1 more source
New laboratory biomarkers of rheumatoid arthritis
Научно-практическая ревматология, 2021 The review presents data on new biomarkers for the diagnosis of rheumatoid arthritis, considers the diagnostic parameters of antibodies to carbamylated proteins, antibodies to peptidyl arginine deaminase, antibodies to homocysteinylated α1-antitrypsin ...
D. A. Dibrov
doaj +1 more source
Therapeutic Advances in Musculoskeletal Disease, 2020 Background: A restricted response against citrullinated peptides/proteins, with less isotype usage, has been found in palindromic rheumatism (PR) in comparison with rheumatoid arthritis (RA).
Raul Castellanos-Moreira +14 more
doaj +1 more source
Egyptian Rheumatology and Rehabilitation, 2021 Background One of the most important and dangerous complications of rheumatoid arthritis (RA) is bone loss, which manifested by erosions and juxta-articular or systemic bone loss.
Manal Shawky Hussein +3 more
doaj +1 more source
Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies. [PDF]
PLoS ONE, 2016 A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA).
Ariana Montes +5 more
doaj +1 more source